RxDoctor Payments Data

Greg Barry, MD

Family Medicine · Clinton Township, MINPI 1831536960

Payments from drug & device makers

$438in general payments, 2019–2025

Across 27 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$121
  • Novo Nordisk$73
  • Astellas Pharma US Inc$57
  • GSK$33
  • Pfizer$33
  • Dynavax Technologies Corporation$30
  • plus $91 from 5 others

What the payments were for

  • Food & beverage$438100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$438 in reported general payments places this provider in the 55th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$93,280
Medicare patients
239
Services billed
2,430

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter117$80,576
OzempicSemaglutide67$77,751
EliquisApixaban73$53,072
TrulicityDulaglutide41$37,495
JardianceEmpagliflozin40$34,791
Repatha SureclickEvolocumab27$30,465
XareltoRivaroxaban26$25,937
MounjaroTirzepatide18$18,445
Spiriva HandihalerTiotropium Bromide13$18,118
LinzessLinaclotide14$17,268
MyrbetriqMirabegron17$11,156
Rosuvastatin Calcium517$9,423
SymbicortBudesonide/Formoterol Fumarate14$6,153
Breo ElliptaFluticasone/Vilanterol12$5,063
Pantoprazole Sodium273$4,782

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$33$85,639129 claims
Novo NordiskOzempic$73$77,75167 claims
Lilly USA, LLCTrulicity, Mounjaro$14$55,93959 claims
PfizerEliquis$33$53,07273 claims
Astellas Pharma US IncMyrbetriq$57$11,15617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Clinton Township

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →